May 04 2018
Sunday, May 20 from 1:00 - 1:30 pm
Thomas Gildea, MD
The Monarch Platform holds promise to fight lung cancer by allowing physicians to diagnose, and eventually treat, hard-to-reach, small peripheral nodules with greater precision than ever before.
The Monarch Platform received U.S. Food and Drug Administration (FDA) clearance in March 2018 for diagnostic and therapeutic bronchoscopic procedures. The platform integrates the latest advancements in robotics, software, data science, and endoscope innovation. It uses a familiar controller interface that physicians use to navigate the flexible robotic endoscope to the periphery of the lung with improved reach, vision, and control.
Hosted from May 18 – May 23, the American Thoracic Society’s International Conference brings in nearly 14,000 pulmonary, critical care, and sleep professionals, all looking to learn the latest advancements in their respective fields from colleagues around the world.